The Hidden Costs of a Prescription for Growth The world of healthcare investing is a complex landscape comprising pharmaceuticals, biotechnology, and medical equipment companies.
Two exchange traded funds (ETFs) have emerged as prominent players: the VanEck Pharmaceutical ETF (PPH) and the State Street Health Care Select Sector SPDR ETF (XLV).
While both offer exposure to global healthcare companies, a closer examination of their cost structures, historical returns, and underlying portfolio concentrations reveals significant differences that may surprise even experienced investors.